At the beginning of the Chinese new year, America Great Health (stock symbol AAGH) released a series of major information such as a press conference and a global sales meeting to launch the first batch of ion-modified peptide series products into the global market
on January 20, Chairman Mike also led a delegation to China, Hong Kong and Macau Special Administrative Regions to continue completing the original itinerary. These important information, especially Chairman Mike’s follow-up itinerary, are related to the laying of the strategic foundation for AAGH to carry on the past and open up the future, and quickly move towards glory. It marks that AAGH’s ion-modified peptide products have suddenly emerged in the global health industry market, with unlimited business opportunities; more importantly, AAGH’s inventive scientist Dr. Tsai’s world-first patented supplement product with protein peptide surface ion modification technology is becoming a patented product owned by AAGH. An exclusive segment of the health industry. This is the advantage of AAGH as a listed company’s high-quality assets and industrial resources, and it will also be a place of favor and competition for capital.
